<DOC>
	<DOCNO>NCT00288106</DOCNO>
	<brief_summary>RATIONALE : Learning long-term effect chemoprevention drug , finasteride , patient prostate cancer may help doctor plan good treatment follow-up care . PURPOSE : This clinical trial follow patient diagnosed prostate cancer undergo treatment either finasteride placebo Prostate Cancer Prevention Trial ( PCPT ) .</brief_summary>
	<brief_title>S0437 Long-Term Follow-Up Patients Who Were Diagnosed With Prostate Cancer PCPT</brief_title>
	<detailed_description>OBJECTIVES : - Compare time metastases patient diagnosed high grade low grade prostate cancer December 31 , 2003 treat finasteride placebo enrol Prostate Cancer Prevention Trial ( SWOG-9217 ) . - Compare difference time secondary therapy definitive therapy radiotherapy radical prostatectomy patient . - Compare difference time prostate-specific antigen recurrence definitive therapy radiotherapy radical prostatectomy patient . - Compare difference all-cause prostate cancer mortality patient . OUTLINE : This multicenter study . Patients stratify accord survival status ( alive v decease ) . Patients provide information general health , prostate cancer treatment history , prostate cancer status ( i.e. , disease progression metastases data ) , prostate-specific antigen ( PSA ) test result baseline every 6 month 8 year . Next kin decease patient ask release patient ' medical record order obtain information patient ' prostate cancer treatment history , prostate cancer progression metastasis , PSA test result , cause death . PROJECTED ACCRUAL : A minimum 75 % 2,401 patient ( n=1800 ) diagnose prostate cancer PCPT need minimal power evaluate objective .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Randomized PCPT Diagnosed prostate cancer December 31 , 2003 DISEASE CHARACTERISTICS : Diagnosed either study site central pathology review PATIENT CHARACTERISTICS : See inclusion criterion PRIOR CONCURRENT THERAPY :</criteria>
	<gender>Male</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>